Skip to content

Category Archives: Efficacy

Stented sleeve implant limits digestion > Device goes down the esophagus into the stomach > Experiment in treating morbid obesity especially in type 2 diabetics > Proximal fixation may prevent migration > Natural Orifices Endoscopic Transluminal Surgery NOTES device > Prior to gastric bypass surgery such as Roux-en-Y Gastric Bypass or Laparoscopic Adjustable Gastric Banding > EndoBarrier device > GI Dynamics

Wednesday, November 5, 2008

Does the food go on the inside of the endobarrier device with the digestive enzymes on the outside of the device? Does the endobarrier device modify metabolic pathways and prevent the mixing of food and digestive enzymes? Does the EndoBarrier stenting device migrate without safe and secure proximal fixation with T fasteners?

IIP > justin > […]

Filed in Safe and secure proximal fixation, Type 2 diabetics, Experiment in treating morbid obesity, Stented sleeve implant limits digestion, Roux-en-Y gastric bypass, Modify metabolic pathways, Hypertension and pulmonary embolus risk, Adjustable Gastric Banding, Prior too gastric bypass surgery, Stented sleeve implant, Incisionless Surgical Technique, GI Dynamics, Reduced post-operative pain, Gastrointestinal and Minimally Invasive Surgery GMIS, Surgical revision, Prevent the mixing of food and digestive enzymes, Digestive enzymes, Endobarrier device, Lining of a portion of the gastrointestinal tract, Safer alternative to gastric bypass, Incisionless Natural Orifice Surgery, Minimally Invasive Surgery MIS, Investigational device, Navigation inside the stomach and abdominal cavity, Natural Orifice Transgastric Endoscopic Surgery NOTES, Transluminal translumenal procedures, Society of American Gastrointestinal and Endoscopic Sur, Medical Device Company, Polaris Venture Partners, Johnson & Johnson Development Corporation, Food bypasses the duodenum and proximal jejunum, More rapid recovery and lower cost, Applicable to wider range of patients, Reversible procedure, Advanced Technology Ventures, Domain Associates, Cutlass Capital, No visible skin scar, scar-free surgery, Efficacy, Minimally invasive surgery techniques, Incision-less solutions, Long-term graft performance, Natural orifices such as the mouth rectum or vagina, Flexible scope, Food and Drug Administration FDA, Flexible endoscopes that have working channels, Using transoral access, Unmet needs in gastrointestinal diseases, Flexible endoscope, Bodies' natural orifices, Natural orifice transluminal endoscopic surgery, High blood pressure, Transoral treatment method, Less-invasive, T fasteners, New suture anchor, Minimally invasive approach, No CPT code, Likely to be widely adopted, organ resections, Diabetes, Reduced risk of adhesions, Entrepreneurs and investors, Venture Capital Financing, Clinical and physiologic patterns, Natural Orifice Transluminal Endoscopic Surgery NOTES, flexible endoscopic sleeve open at both ends, Tie-knot device approximates the suture ends, Gastrotomy, Substantial learning curve, Innovative Hybrid T-fasteners, endoluminal bariatric surgery, Bariatric sleeve, endoscopic gastric reduction, No Scar Surgery | Comments Off

Biosensors International Group > Receives CE Mark Approval for its BioMatrix Drug-Eluting Coronary Stent System > BioMatrix and NOBORI drug-eluting stents > Stents incorporate a biodegradable polymer coating together with an immunosuppressive drug

Saturday, January 19, 2008

Will BioMatrix provide a valuable alternative to the drug-eluting stents currently available to interventional cardiologists? Is the three-year follow-up data released at the Transcatheter Cardiovascular Therapeutics Conference showing BioMatrix’s superior results in terms of safety and clinical effectiveness? Will the increasing complexity of worldwide regulatory requirements make it more difficult in the future to introduce […]

Filed in PLA polymer fully degrades into water and carbon dioxid, Leaving in place a biocompatible stent surface, Drug has a higher lipophilic and hydrophobic profile, Immunosuppressive and anti-inflammatory properties, NOBORI drug-eluting stent system, Polymer coated onto the outer abluminal side of the ste, Drug to be released to targeted tissue, Transcatheter Cardiovascular Therapeutics Conference, Siegburg Heart Center, Eberhard Grube, Three separate drug-eluting stent programs, Terumo Corporation, Biolimus A9 biodegradable polymer and advanced stent de, Biosensors International Group, Medical Device Company, Efficacy, Medical Universities Research Institutes Med Societies, BioMatrix, Axxion, BioMatrix clinical trial program, Drug eluting stents, Licensed aspects of its drug-eluting stent technology t, BioMatrixFreedom polymer-free drug-eluting stent, Endoluminal Endolumenal Hollow Vessel | Comments (0)

Stented sleeve implant limits digestion > Device goes down the esophagus into the stomach > Experiment in treating morbid obesity especially in type 2 diabetics > Proximal fixation may prevent migration > Natural Orifices Endoscopic Transluminal Surgery NOTES device > Prior to gastric bypass surgery such as Roux-en-Y Gastric Bypass or Laparoscopic Adjustable Gastric Banding > EndoBarrier device > GI Dynamics

Friday, December 28, 2007

Does the food go on the inside of the endobarrier device with the digestive enzymes on the outside of the device? Does the endobarrier device modify metabolic pathways and prevent the mixing of food and digestive enzymes? Does the EndoBarrier stenting device migrate without safe and secure proximal fixation with T fasteners?

IIP > justin > […]

Filed in Digestive enzymes, Endobarrier device, Society of American Gastrointestinal and Endoscopic Sur, Incisionless Natural Orifice Surgery, Prevent the mixing of food and digestive enzymes, Stented sleeve implant, Experiment in treating morbid obesity, Experiment in treating morbid obesity, Prior too gastric bypass surgery, Surgical revision, Gastrointestinal and Minimally Invasive Surgery GMIS, scar-free surgery, Entrepreneurs and investors, Venture Capital Financing, No visible skin scar, Reduced post-operative pain, Incisionless Surgical Technique, Medical Device Company, GI Dynamics, Type 2 diabetics, Safe and secure proximal fixation, Advanced Technology Ventures, Reversible procedure, Food bypasses the duodenum and proximal jejunum, Cutlass Capital, Domain Associates, Investigational device, Polaris Venture Partners, Johnson & Johnson Development Corporation, More rapid recovery and lower cost, Applicable to wider range of patients, Roux-en-Y gastric bypass, Stented sleeve implant limits digestion, Safe and secure proximal fixation, Adjustable Gastric Banding, Hypertension and pulmonary embolus risk, Safer alternative to gastric bypass, Lining of a portion of the gastrointestinal tract, Modify metabolic pathways, Clinical and physiologic patterns, Reduced risk of adhesions, Incision-less solutions, Using transoral access, Unmet needs in gastrointestinal diseases, Minimally invasive surgery techniques, Efficacy, Flexible endoscopes that have working channels, Natural orifices such as the mouth rectum or vagina, Long-term graft performance, Less-invasive, T fasteners, No Scar Surgery, Minimally Invasive Surgery MIS, Natural Orifice Transluminal Endoscopic Surgery, Natural orifice transluminal endoscopic surgery, Bodies' natural orifices, Transoral treatment method, High blood pressure, Flexible endoscope, Food and Drug Administration FDA, Flexible scope, Natural Orifice Transgastric Endoscopic Surgery NOTES, Natural Orifice Transluminal Endoscopic Surgery NOTES, flexible endoscopic sleeve open at both ends, organ resections, Navigation inside the stomach and abdominal cavity, Diabetes, No CPT code, Likely to be widely adopted, Bariatric sleeve, endoscopic gastric reduction, Substantial learning curve, Minimally invasive approach, New suture anchor, Gastrotomy, Transluminal translumenal procedures, endoluminal bariatric surgery, Innovative Hybrid T-fasteners, Tie-knot device approximates the suture ends, Ideas For Surgery News | Comments (0)

Minimally invasive surgery techniques replacing endoaneurysmorrhaphy > Laparoscopic permanent repair of Abdominal Aortic Aneurysm AAA

Monday, September 3, 2007

Is elective surgical treatment of AAA the most reasonable approach to prevent the mortality associated with this disorder? Can abdominal aortic aneurysms be treated successfully by elective surgical replacement with synthetic graft in a laparoscopic procedure? Are the laparoscopic techniques well refined and ready for widespread adaptation?

Over the last decade, minimally invasive surgical techniques have […]

Filed in Efficacy, Non-randomised controlled trials, Small skin incisions, Insertion of one of the surgeon’s hands, Midline minilaparotomy incision, Following open repair, Endovascular stenting, Long-term graft performance, Need for reintervention, Open conversion rates, Successful complete repair, Totally laparoscopic surgery TLS, Hand-assisted laparoscopic surgery HALS, Laparoscopic vascular surgery instruments, Endoaneurysmorrhaphy, Elective surgical treatment of AAA, Laparoscopic permanent repair of Aortic Aneurysm, Surgeon experience, Totally laparoscopic AAA replacement, Laparoscopic repair of abdominal aortic aneurysm, Open surgical repair, Traditional treatment for abdominal aortic aneurysm, Larger aneurysms can leak or rupture, Minimally invasive surgery techniques | Comments (0)